Skip to main content

Monensin

ADVERTISEMENT
Identification
Molecular formula
C36H62O11
CAS number
17090-79-8
IUPAC name
8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one
State
State
Monensin is typically found as a solid at room temperature, often in a crystalline powder form.
Melting point (Celsius)
103.00
Melting point (Kelvin)
376.15
Boiling point (Celsius)
0.00
Boiling point (Kelvin)
0.00
General information
Molecular weight
671.88g/mol
Molar mass
671.8790g/mol
Density
1.2603g/cm3
Appearence

Monensin is a white to pale yellow crystalline powder. It is slightly soluble in water but dissolves in organic solvents. It has no distinctive odor and is typically found in the solid state for its applications.

Comment on solubility

Solubility of 8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one

The solubility of 8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one is an intriguing subject due to its complex structure and functional groups.

Several factors can influence the solubility of this compound:

  • Polarity: The presence of multiple hydroxyl groups (-OH) suggests that the compound may exhibit some level of hydrophilicity, potentially allowing it to dissolve in polar solvents such as water.
  • Functional Groups: The triol part of the molecule can engage in hydrogen bonding, which will enhance its solubility in protic solvents.
  • Hydrophobic Regions: However, the bicyclic structure may introduce some hydrophobic characteristics, leading to a decrease in solubility in polar solvents while potentially increasing solubility in non-polar solvents.
  • Concentration of the solution: As with many organic compounds, higher concentrations can lead to different solubility behaviors.

While specific solubility data for this compound may not be readily available, it can be expected that:

  • In water: It may show moderate solubility due to the hydroxyl groups.
  • In organic solvents: Compounds with similar structures often show better solubility in non-polar or less polar solvents.

Thus, it can be summarized that the solubility characteristics of 8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one likely present a complex interplay of hydrophilic and hydrophobic interactions, influenced by its unique structure.

Interesting facts

Interesting Facts about 8,16,18-Trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one

This compound belongs to a class of cyclic compounds known for their intricate structures and significant biological activities. Its detailed nomenclature indicates a rich molecular frame that can intrigue both chemists and biologists alike. Here are some compelling aspects about this compound:

  • Complex Structure: The bicyclic nature of the compound, specifically the bicyclo[12.4.0] portion, suggests a unique versatility in chemical reactivity and possible applications in drug design.
  • Hydroxyl Groups: With three hydroxyl groups at positions 8, 16, and 18, the potential for hydrogen bonding is substantial, influencing both solubility and reactivity.
  • Bioactivity: Compounds with similar structural frameworks have been investigated for their therapeutic properties, particularly in areas such as anti-inflammatory and anti-cancer research.
  • Natural Occurrence: Many related compounds are found in nature, serving as secondary metabolites in plants, which play vital roles in ecological interactions.
  • Research Potential: This compound's complex arrangement is a fascinating topic for synthetic organic chemists aiming to explore novel synthesis pathways or modification strategies.

Overall, the study of 8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one reflects the intersection of chemistry, biology, and medicinal research, emphasizing the significance of molecular diversity in developing new therapeutic agents.

Synonyms
Ralgro
55331-29-8
Frideron
Ralone
P 1496
8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one
alpha zearalanol
Ralabol (TN)
7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one
Zeranol (USAN/INN)
Zeranol [USAN:INN:BAN]
Zerano
Zeranol standard
1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-; Zeranol (racemic)
Zeranol (4)
A-ZEARALANOL
THFES(HM)
6-(6,10-Dihydroxyundecyl)-beta-resorcylic acid, mu-lactone
Zeranol, BAN, INN, USAN
SCHEMBL2602612
DTXSID70860370
DWTTZBARDOXEAM-UHFFFAOYSA-N
BDBM235684
HMS3370D21
HMS3370F15
HMS3393F11
(3S,7X)-3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one
FCA33129
AKOS001029828
Dihydroxyundecyl Resorcylic Acid Lactone
NCGC00184708-02
NCGC00184708-04
1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-
AC-14977
DB-050911
NS00000193
AB01209732-01
AB01209732-04
6-(6,10-Dihydroxyundecyl)-.beta.-resorcylic acid, .mu.-lactone
(6X,10S)-6-(6,10-Dihydroxyundecyl)-.beta.-resorcylic acid .mu.-lactone
1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3S,7X)-
7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one-, (3S-(3R*,7S*))-